Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 October 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Pathophysiological abnormalities in functional dyspepsia

The most recent issue of the American Journal of Gastroenterology reports pathophysiological abnormalities in functional dyspepsia subgroups according to the Rome III criteria.

News image

The Rome III criteria proposed to subdivide functional dyspepsia into a postprandial distress syndrome group, characterized by the presence of postprandial fullness and/or early satiety, and an epigastric pain syndrome group, characterized by the presence of epigastric pain and/or epigastric burning. 

It has been suggested that different pathophysiological mechanisms underlie the symptom presentations in these subgroups that might determine treatment choices. 

Dr Tack and colleagues from Belgium investigated the prevalence of gastric sensorimotor dysfunction in the postprandial distress syndrome, epigastric pain syndrome, and overlap groups.

The researchers evaluated potential differential associations with dyspeptic symptom scores.

The prevalence of gastric hypersensitivity was 37%
American Journal of Gastroenterology
The team recruited consecutive functional dyspepsia patients fulfilling Rome III criteria, and they scored frequency of dyspeptic symptoms over the past 3 months. 

The cumulative symptom score was calculated by adding up the score of these dyspeptic symptoms. 

Based on these symptom scores, the patients were subdivided into subgroups according to the Rome III consensus.

Group 1 included postprandial distress syndrome, characterized by postprandial fullness and/or early satiety at least several times a week.

Group 2 included epigastric pain syndrome, characterized by epigastric pain and/or epigastric burning at least once a week.

Group 3 was an overlap group, fulfilling the criteria for both postprandial distress syndrome and epigastric pain syndrome. 

Gastric sensitivity and gastric accommodation were measured using barostat testing, and solid gastric emptying was determined using the [14C]octanoate breath test.

A total of 560 functional dyspepsia patients were classified into postprandial distress syndrome, epigastric pain syndrome, and overlap groups.

The prevalence of gastric hypersensitivity, impaired gastric accommodation, and delayed gastric emptying were 37%, 37%, and 23%, respectively, without any differential distribution in Rome III subgroups. 

Comparing the physiological parameters for these gastric sensorimotor functions, the team found only a significant difference in the gastric half emptying time between subgroups, with the overlap group having a higher half time compared with the epigastric pain syndrome group. 

In the overlap group, the researchers noted that gastric hypersensitivity was associated with the severity of postprandial distress syndrome symptoms, epigastric pain syndrome symptoms, and the cumulative symptom score, whereas delayed gastric emptying was associated with nausea, and the cumulative symptom score.

Dr Tack's team comments, "Except for gastric emptying in the overlap group, functional dyspepsia subgroups as defined by the Rome III criteria are not differentially associated with putative pathophysiological mechanisms."

"These observations question the utility of this classification for guiding therapeutic choices in clinical practice."

Am J Gastroenterol 2017; 112:132–140
20 January 2017

Go to top of page Email this page Email this page to a colleague

 19 October 2017 
Surgical anastomosis at 1-year colorectal cancer surveillance
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites
 18 October 2017 
Predicting recurrence after curative rectal cancer surgery
 18 October 2017 
Hep E seroprevalence and hemodialysis
 18 October 2017 
Prebiotic and changes in the human gut microbiota
 17 October 2017 
Laparoscopic surgery use in Medicare patients with colon cancer
 17 October 2017 
Medication nonadherence and health care costs
 17 October 2017 
Asthma and IBD development
 16 October 2017 
Colorectal cancer screening and postpolypectomy surveillance colonoscopy
 16 October 2017 
Continuity of care after colorectal surgery
 16 October 2017 
Breastfeeding and the risk of IBD
 13 October 2017 
Treating patients with HCV and severe renal impairment
 13 October 2017 
Blood pressure management during abdominal surgery
 13 October 2017 
Food elimination diets for eosinophilic esophagitis
 12 October 2017 
Global recurrence of H. pylori
 12 October 2017 
Colonoscopy in an organized colorectal cancer screening program 
 12 October 2017 
Predicting advanced fibrosis in chronic hepatitis B
 11 October 2017 
Fecal microbiota transplantation for ulcerative colitis
 11 October 2017 
Sexual functioning in Hep C
 11 October 2017 
Ulcerative proctitis in pediatric-onset UC
 10 October 2017 
Quality standards in upper gastrointestinal endoscopy
 10 October 2017 
Eosinophilic esophagitis and swallowed topical corticosteroids
 10 October 2017 
Follow-up of positive results on fecal blood tests
 09 October 2017 
Diverticulitis and emergency department burden
 09 October 2017 
Clostridium difficile infection after ileostomy reversal
 09 October 2017 
Global recurrence rate of H. pylori
 06 October 2017 
Predicting nontreatment for Hep C
 06 October 2017 
Cow's milk–based formula and development of celiac disease
 06 October 2017 
Propofol for outpatient colonoscopy
 05 October 2017 
Pediatric candidates on the transplant wait list
 05 October 2017 
Incidence of sepsis in the USA
 05 October 2017 
Quality of life after chemoradiation in rectal cancer
 04 October 2017 
Peptic ulcer disease diagnosed in acute upper endoscopy
 04 October 2017 
Clinical practice guidelines in colon cancer
 04 October 2017 
Rural residence and risk of IBD
 03 October 2017 
Novel candidate risk genes for IBD
 03 October 2017 
Antibody tests and detecting celiac disease
 03 October 2017 
Environmental factors and IBD
 02 October 2017 
Full publication of Gastroenerology abstracts
 02 October 2017 
Interferon-free therapy in advanced liver disease
 02 October 2017 
Burden of NAFLD with advanced fibrosis in the USA
 29 September 2017 
Inpatient Gastroenterology training experience
 29 September 2017 
Proteomic analysis of IBD
 28 September 2017 
Incidence of biopsy-verified celiac disease
 28 September 2017 
Social networking-based discussion group by ERCP doctors
 27 September 2017 
Function of trypsin-3 in IBS
 27 September 2017 
Predictors of nonadherence in IBD
 27 September 2017 
Hep C treatment in the era of direct-acting anti-viral agents
 26 September 2017 
Chronic pancreatitis and pancreatic cancer risk
 26 September 2017 
Factors associated with the risk of metachronous gastric neoplasm
 26 September 2017 
Treatment of hyperactive delirium in advanced cancer
 25 September 2017 
Lenalidomide for advanced liver cancer
 25 September 2017 
Silibinin nanoparticles inhibit HCV infection
 22 September 2017 
Perforation after colonic endoscopic mucosal resection
 22 September 2017 
Medical management and colectomy rates
 22 September 2017 
MRI for liver metastatic colorectal cancer
 21 September 2017 
Adenomatous colorectal polyps in young cancer survivors
 21 September 2017 
Predicting mucosal healing in treated celiac disease patients
 21 September 2017 
Antireflux surgery and recurrence of GERD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us